The policy will allow licensed professionals to use certain wellness-focused peptides not approved by the FDA in their compounded medicines.
Anthropic hopes Powerful AI will “match or exceed the cognitive capabilities of top human experts across scientific disciplines”.
Xtandi's label as the cancer treatment paradigm shifts towards the use of mutation-specific targeted therapies.
Reaction from the life sciences industry to the Autumn Budget was mixed, with the government opting for a more macro focus on business scaling.
Gaelic Labs is eyeing competitive benefits from its 2025 acquisition of fellow Irish beta-lactams manufacturer and further expansion.
Formation Bio has launched the Formation Bio Drug Development Accelerator Fund to broaden the company's clinical-stage medicines portfolio.